COST Action CA16225 "Realising the therapeutic potential of novel cardioprotective therapies" (External organisation)

Activity: Membership typesMembership of network

Description

COST Action CA16225 "Realising the therapeutic potential of novel cardioprotective therapies" Representative of Latvia in the Steering Committee
Period19 Oct 201718 Apr 2022
Held atCOST Action CA16225 "Realising the therapeutic potential of novel cardioprotective therapies", Belgium
Degree of RecognitionInternational